Testosterone replacement therapy is associated with a modest reduction in depressive symptoms in men with confirmed low testosterone, especially those with clinically diagnosed depression, but it is not an FDA-approved treatment for depression and the effect is inconsistent across studies. The strongest evidence comes from men who are both hypogonadal and depressed, not from healthy men hoping TRT will fix an unrelated mood problem.
What the biggest studies actually found
The Testosterone Trials, a set of NIH-funded randomized controlled trials published in the New England Journal of Medicine, tested testosterone gel against placebo in men over 65 with low testosterone. The Vitality Trial component measured mood and energy as secondary outcomes and found improvements in mood and depressive symptoms among men who started with low vitality and low libido, even though the trial's primary energy measure did not reach statistical significance (Snyder et al., N Engl J Med, 2016). That distinction matters: testosterone moved the needle on mood specifically, not on every measure researchers tracked.
A 2019 systematic review and meta-analysis in JAMA Psychiatry pooled data across multiple randomized trials and found testosterone treatment was associated with a statistically significant reduction in depressive symptoms compared to placebo, with the effect strongest in men who had both low testosterone and a diagnosed depressive disorder (Walther et al., JAMA Psychiatry, 2019). In men without confirmed hypogonadism, the antidepressant effect was smaller and less consistent.
Why low testosterone and depression overlap in the first place
Hypogonadism and depression share overlapping symptoms, low energy, poor concentration, disrupted sleep, reduced interest in activities, which makes it hard to tell from symptoms alone which condition is driving the picture (Bhasin et al., Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2018). Testosterone also has direct effects on brain chemistry, including interactions with serotonin and dopamine pathways, which gives a plausible biological reason mood could improve alongside a rising testosterone level rather than simply because the man feels physically better.
This overlap is also why testosterone testing before starting TRT matters so much for anyone whose main complaint is mood. Treating a mood problem with testosterone when levels are actually normal is treating the wrong variable, and it delays getting to therapies that are proven to work for depression on their own.
Who is most likely to see a mood benefit
The pattern across trials is consistent: men with lab-confirmed low testosterone and clinically significant depressive symptoms see the clearest benefit, while men with normal testosterone or only mild, situational low mood see little to no measurable effect from TRT (Walther et al., JAMA Psychiatry, 2019). Men in this group also tend to report improvements in related symptoms, like low libido and fatigue, alongside the mood change, which fits with testosterone correcting a physiological deficiency rather than acting as a standalone antidepressant.
Age and baseline severity matter too. Older men with more pronounced hypogonadal symptoms in the T-Trials data showed more consistent mood benefit than younger men with borderline-low levels, reinforcing that TRT works best as a treatment for a diagnosed deficiency, not a general mood enhancer.
What TRT is not proven to do for mood
No major testosterone product carries an FDA-approved indication for depression, and the Endocrine Society guideline explicitly does not recommend testosterone therapy as a primary or standalone treatment for depression in men with normal testosterone levels (Bhasin et al., Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2018). If depression is severe, involves suicidal thoughts, or exists independent of any testosterone deficiency, established treatments like therapy and antidepressant medication remain the first-line approach, and a mental health professional should be part of that conversation regardless of what a testosterone level shows.
It is also worth being skeptical of clinics that market TRT primarily as a mood or anxiety fix without first confirming low testosterone on two separate morning blood draws, since that is the diagnostic standard the research above is actually built on.
